Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01352000 · ClinicalTrials.gov registry record · NA
Relapse-Prevention Booklets as an Adjunct to a Tobacco Telephone Helpline("Quitline")
A NA study, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 3,830
- Enrollment target
NCT01352000 is a NA study that has completed, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 3,830 participants.
The verdict
NCT01352000, a NA study, has completed, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 3,830 participants
- Enrollment target
Study Summary
The study primary purpose is smoking relapse prevention. This study is a collaboration between researchers who developed the relapse-prevention intervention, at the H. Lee Moffitt Cancer Center in Tampa, Florida, and those associated with the "New York State Smokers' Quitline" (NYSSQL), at Roswell Park Cancer Institute in Buffalo, New York.
Interventions
- BEHAVIORAL Smoking Cessation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,830 participants |
| Start Date | 2008-12 |
| Est. Completion | 2016-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01352000
The ClinicalTrials.gov registry entry for NCT01352000 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 3,830 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is H. Lee Moffitt Cancer Center and Research Institute, which has 502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Smoking Cessation is the first listed.
NCT01352000 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01352000 about?
NCT01352000 is a clinical study titled "Relapse-Prevention Booklets as an Adjunct to a Tobacco Telephone Helpline("Quitline")". The study primary purpose is smoking relapse prevention. This study is a collaboration between researchers who developed the relapse-prevention intervention, at the H. Lee Moffitt Cancer Center in Tampa, Florida, and those associated with the "New York State Smokers' Quitline" (NYSSQL), at Roswell P...
What is the current status of trial NCT01352000?
This trial is currently completed. It is a NA study. The enrollment target is 3,830 participants. The study started on 2008-12. Estimated completion is 2016-10.
What interventions are being tested in trial NCT01352000?
The interventions under investigation include: Smoking Cessation (BEHAVIORAL).
Who is sponsoring clinical trial NCT01352000?
This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.